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ABSTRACT: Exhaled air condensate provides a noninvasive means of obtaining
samples from the lower respiratory tract. Hydrogen peroxide (H2O2) in exhaled
air has been proposed as a marker of airway inflammation. We hypothesized that
in stable asthmatic children the H2O2 concentration in exhaled air condensate may
be elevated as a result of airway inflammation.
In a cross-sectional study, 66 allergic asthmatic children (of whom, 41 were treat-
ed with inhaled steroids) and 21 healthy controls exhaled through a cold trap. The
resulting condensate was examined fluorimetrically for the presence of H2O2. All
subjects were clinically stable, nonsmokers, without infection. 
The median H2O2 level in the exhaled air condensate of the asthmatic patients
was significantly higher than in healthy controls (0.60 and 0.15 µmol, respective-
ly; p<0.05), largely because of high values in the stable asthmatic children who did
not use anti-inflammatory treatment (0.8 µmol; p<0.01 compared to controls).
We conclude that hydrogen peroxide is elevated in exhaled air condensate of
children with stable asthma, and may reflect airway inflammation.
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Our present understanding of asthma as a disease of
airway inflammation has been greatly enhanced by stud-
ies using bronchoalveolar lavage (BAL) [1]. In young
children, BAL is generally not acceptable for diagnos-
tic and monitoring purposes. A noninvasive method to
assess airway inflammation is important for this group
[2]. Exhaled air condensate has been proposed as a non-
invasive means of obtaining samples from the lower respi-
ratory tract, based on the hypothesis that aerosol particles
excreted in breath may reflect the composition of the low-
er airway fluids [3]. Several investigators have analysed
exhaled air condensate for different mediators of inflam-
mation [3–5]; however, data on children are scanty [5].
Hydrogen peroxide (H2O2) is a putative marker of air-
way inflammation in exhaled air: inflammatory cells prod-
uce H2O2 [6], which causes lung inflammation and damage[7–9]; stimulated alveolar macrophages from asthmatics
generate more reactive oxygen species than alveolar mac-
rophages from healthy subjects [10]. Indeed, an increased
content of H2O2 has been described in various inflam-
matory lung disorders: in exhaled air of cigarette smok-
ers [11]; patients with adult respiratory distress syndrome
(ARDS) [12, 13]; and patients with acute hypoxaemic
respiratory failure [14]. DOHLMAN et al. [5] described an
increased H2O2 concentration in exhaled air condensate
in a small group of asthmatic children, mainly in those
with acute disease. As inflammation is also likely to be
present in symptom-free asthmatics [15], we hypothesi-
zed that the H2O2 concentration may also be elevated
in exhaled air condensate of children with stable asthma,
and may serve as a marker of airway inflammation.
Patients and methods
Study population
Sixty six asthmatic children (23 girls and 43 boys)
attending the out-patient clinic of Sophia Children's Hos-
pital were included in the study. Asthma was diagnosed
on clinical grounds following international guidelines
[16]. Appropriate therapy was prescribed by the patient's
own physician, and had not been changed during the
3 months preceding the study. All 66 patients used an
inhaled bronchodilator on demand, and 41 (15 girls and
26 boys) used an inhaled corticosteroid daily. The med-
ian age of those without steroids was 12.6 yrs, and of
those receiving steroids was 11.1 yrs. All were lifelong
nonsmokers and were clinically stable. All had bron-
chial hyperresponsiveness (provocative dose of inhaled
methacholine that produced a 20% fall in forced expi-
ratory volume in one second (PD20) of <150 µg) docu-
mented in the past, and had allergy as documented by
radio allergosorbent test (RAST) class 2 or higher for
at least one common airborne allergen. Control sub-
jects were healthy, nonsmoking young adult volunteers
(median age 25 yrs), with no history of allergy and res-
piratory disease, nor of any other chronic illness, and
used no medication. None of the subjects had had
symptoms of acute respiratory infection within the month
before the condensate was collected. The study was
approved by the Hospital Ethical Committee.
Collection of exhaled air condensate
Exhaled air condensate was obtained by passing ex-
pired air through a 50 cm double-jacketed glass tube cool-
ed to a temperature of 0°C by means of countercurrent
circulating iced water. The subjects breathed through a
mouthpiece and a two-way nonrebreathing valve (Rudolph,
Kansas City, USA), which also served as a saliva trap.
They were asked to breathe at a normal frequency and
tidal volume, wearing a noseclip, for a period of 10–15
min. The condensate, at least 1 mL, was collected on ice.
Lung function
All subjects underwent flow-volume measurements
immediately after collection of the condensate. Flow-
volume curves were obtained in triplicate, using a Lilly-
type pneumotachograph (Masterlab Jaeger, Würzberg,
Germany) before and after inhalation of 1 mg of terbu-
taline powder (Turbohaler®). Results were expressed as
percentage predicted [17].
Hydrogen peroxide
The concentration of H2O2 in exhaled air condensate
was determined by means a fluorimetric assay based on
the reaction of H2O2 with horseradish peroxidase to form
a compound which oxidizes p-hydroxyphenylacetic acid
to a fluorescent product [18]. Briefly, 400 µL of con-
densate was mixed with 1.5 mM (10 µL) p-hydroxy-
phenylacetic acid and 100 µg·mL-1 (4 µL) horseradish
peroxidase (both Sigma Chemical Co., St. Louis, MO,
USA) immediately after collection, and frozen at -20°C.
The fluorescent product of the condensate and of stan-
dard solutions of H2O2 were measured with a fluorime-
ter (model 3000; Perkin-Elmer, Norwalk, USA) at an
excitation wavelength of 295 nm and an emission wave-
length of 405 nm. The lower limit of H2O2 detection was
0.1 µM. Concentrations of H2O2 in condensate were
obtained by linear interpolation of a standard curve.
Preliminary observations in a limited number of young
healthy adults indicated that, with this method, the with-
in-subject between-days variations were within 0.1 µmol.
Data analysis
Results are expressed as median and range because of
a nonsymmetrical distribution and because some values
were below the detection limit. Since the anti-inflam-
matory action of inhaled steroids could be a confound-
ing factor influencing H2O2 in exhaled air condensate as
marker of airway inflammation, subgroups with and
without steroids were analysed separately. Comparisons
between groups were made by the Mann-Whitney test
for two unpaired independent samples. A two tailed p-
value of less than 0.05 was considered significant. There
were insufficient data to perform a formal power calcu-
lation, but we reasoned that with a group size of 20 sub-
jects we should be able to detect a 1 SD difference (our
own preliminary observations suggested this to be about
20%) at a two-sided alpha of 0.05 with a power of 90%.
Results
All subjects completed the protocol without difficulty.
The time to collect at least 1 mL of condensate varied
between 10–15 min.
Lung function measurement in asthmatic children
without steroids showed near normal values (mean
forced vital capacity (FVC) 93% pred, forced expirato-
ry volume in one second (FEV1) 100% pred, increase in
FEV1 after 1 mg inhaled terbutaline 7%). Asthmatics with
steroids were slightly better (FVC 100% pred, FEV1
107% pred, increase in FEV1 after terbutaline 6%; but
not significantly different from the children without ster-
oids). Controls all had a normal lung function (mean
FVC 108% pred, FEV1 111%, increase in FEV1 after ter-
butaline 3%).
The median H2O2 concentration in condensates of all
asthmatic children was significantly higher than in con-
densate from healthy control subjects (0.60 and 0.15
µmol, respectively; p<0.05). The median H2O2 concen-
tration in the asthmatics who used steroids (0.45 µmol)
was higher than in healthy control subjects, but the dif-
ference was not significant. There was a highly signif-
icant difference in median H2O2 concentration between
asthmatics without anti-inflammatory treatment and hea-
lthy controls (0.8 µmol and 0.15 µmol, respectively;
p<0.01). Individual data are shown in figure 1. There
was no correlation between the concentration of exhaled
H2O2 and the change in FEV1 before and after bron-
chodilatation in control subjects or in asthmatic patients.
Furthermore, no correlation was found between the daily
dose of inhaled steroids and H2O2 concentration in the
condensate (data not shown).
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Fig. 1.  –  Concentration of H2O2 in exhaled air condensate of stable
asthmatic children and healthy control subjects. The asthmatics are
divided into a subgroup using inhaled corticosteroids (ICS+), and a
group without anti-inflammatory treatment (ICS-). Each dot represents
one patient.  Median values are indicated by a horizontal line (     )
and the detection limit by a horizontal broken line (    ). The differ-
ences between median values of healthy subjects and all asthmatic
subjects was significant (0.15 and 0.60 µmol, resectively; p<0.05), the
difference between healthy subjects and the asthmatics without steroids
was highly significant (0.15 and 0.80 µmol, respectively; p<0.01).
Discussion
This study is the first to demonstrate a significantly
increased concentration of H2O2 in exhaled air conden-
sate from stable asthmatic children compared to healthy
controls. That the H2O2 concentrations are lower in
asthmatics who use anti-inflammatory medication sup-
ports the hypothesis that exhaled H2O2 reflects the pres-
ence of airway inflammation.
The present results seem different from those of an
earlier study by DOHLMAN et al. [5], describing increased
H2O2 concentration in exhaled air condensate in a small
group of asthmatic children with acute respiratory dis-
ease, whereas exhaled H2O2 from stable asthmatics was
not different from control subjects. Both studies used
similar control groups. We think that the much larger
groups in the present study, and the separation of asth-
matics with and without anti-inflammatory treatment
explain the different outcomes.
The present study shows that inhaled steroids are ass-
ociated with lower exhaled H2O2 concentrations in asthm-
atics. A study in ARDS patients treated with corticosteroids
showed a tendency towards lower levels of H2O2 in the
exhaled air condensate as compared to ARDS patients
not receiving corticosteroids [14]. The present cross-
sectional study cannot demonstrate a causal relationship
between steroid use and lower exhaled peroxide; prospec-
tive controlled intervention studies are needed for that
purpose.
An increased content of H2O2 has also been reported
in other inflammatory respiratory diseases [11–14]. This
means that exhaled H2O2 is probably not a specific diag-
nostic test for asthma. Rather than a diagnostic test,
exhaled peroxide may be used to guide anti-inflamma-
tory treatment and estimate disease severity over time
within subjects.
It can be argued that the control subjects in the pre-
sent study were not age-matched, and that age-depen-
dent changes in exhaled peroxide might partly explain
the results. This seems unlikely: there are no data sug-
gesting that healthy children produce more reactive oxy-
gen species in their airways than healthy young adults.
However, we do feel that, in the absence of such data,
establishing normal values over a wide age range is an
important goal for the near future.
In conclusion, this cross-sectional study has shown
that the concentration of H2O2 in exhaled air conden-
sate is increased in stable asthmatic children, and lower
in patients receiving anti-inflammatory treatment, sug-
gesting that airway inflammation increases exhaled per-
oxide. Correlation of H2O2 in exhaled air condensate
with invasive measures of airway inflammation, such as
bronchial biopsies, is needed to validate the hypothesis
that exhaled peroxide reflects airway inflammation. On
the basis of the present findings, we believe that the con-
centration of hydrogen peroxide in exhaled air is a poten-
tially useful marker of airway inflammation in asthmatic
children, especially since the procedure is quick and easy
to perform. Further studies should explore its value as a
noninvasive test, e.g. for monitoring effects of anti-inflam-
matory therapy.
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